title: Post transplant lymphoproliferative disease: detection of tumor by Tc99m sestaMIBI and treatment with rituximab.
authors.forename: S
authors.initials: S
authors.lastname: Paydas
authors.forename: Z
authors.initials: Z
authors.lastname: Yapar
authors.forename: M
authors.initials: M
authors.lastname: Ergin
authors.forename: I B
authors.initials: IB
authors.lastname: Guney
authors.forename: U
authors.initials: U
authors.lastname: Disel
authors.forename: S
authors.initials: S
authors.lastname: Yavuz
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D000069283:Rituximab; D017256:Technetium Tc 99m Sestamibi
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D017256:Technetium Tc 99m Sestamibi